JP2022517531A5 - - Google Patents

Info

Publication number
JP2022517531A5
JP2022517531A5 JP2021537075A JP2021537075A JP2022517531A5 JP 2022517531 A5 JP2022517531 A5 JP 2022517531A5 JP 2021537075 A JP2021537075 A JP 2021537075A JP 2021537075 A JP2021537075 A JP 2021537075A JP 2022517531 A5 JP2022517531 A5 JP 2022517531A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
mscs
hscs
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021537075A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517531A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/014041 external-priority patent/WO2020150580A1/en
Publication of JP2022517531A publication Critical patent/JP2022517531A/ja
Publication of JP2022517531A5 publication Critical patent/JP2022517531A5/ja
Pending legal-status Critical Current

Links

JP2021537075A 2019-01-18 2020-01-17 神経学的疾患のための二重幹細胞治療 Pending JP2022517531A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962794041P 2019-01-18 2019-01-18
US62/794,041 2019-01-18
PCT/US2020/014041 WO2020150580A1 (en) 2019-01-18 2020-01-17 Dual stem cell therapy for neurological conditions

Publications (2)

Publication Number Publication Date
JP2022517531A JP2022517531A (ja) 2022-03-09
JP2022517531A5 true JP2022517531A5 (https=) 2022-10-21

Family

ID=71614511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021537075A Pending JP2022517531A (ja) 2019-01-18 2020-01-17 神経学的疾患のための二重幹細胞治療

Country Status (5)

Country Link
US (1) US20220072050A1 (https=)
EP (1) EP3911342A4 (https=)
JP (1) JP2022517531A (https=)
CA (1) CA3127090A1 (https=)
WO (1) WO2020150580A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200261726A1 (en) * 2017-10-05 2020-08-20 The Board Of Trustees Of The Leland Stanford Junior University Conductive Polymer Implant, combining electrical and chemical stimulation to improve neural recovery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069597A1 (en) * 1999-07-01 2005-03-31 Thompson Ronald J. Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of alprostadil for the treatment of female sexual dysfunction
AU2003217350A1 (en) * 2002-02-08 2003-09-02 University Of Chile Proliferated cell lines and uses thereof
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
EP1608411B1 (en) * 2003-04-01 2010-09-29 United States Government as represented by the Department of Veteran's Affaires Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure.
US8609082B2 (en) * 2005-01-25 2013-12-17 Bio Control Medical Ltd. Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis
WO2009011546A2 (en) * 2007-07-16 2009-01-22 Catholic University Industry Academic Cooperation Foundation Method for promoting the self-renewal of adult stem cells using mesenchymal stromal cells
US11707488B2 (en) * 2015-08-28 2023-07-25 Rohto Pharmaceutical Co., Ltd. ROR1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ROR1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating disease using ROR1-positive mesenchymal stem cells
EP3231434A1 (en) * 2016-04-14 2017-10-18 Fundacio Centre de Regulacio Genomica Method of treatment of parkinsonism

Similar Documents

Publication Publication Date Title
JP2025503791A (ja) 毛包修復タンパク質組成物及びその作製方法とその使用
TW201805010A (zh) 用於促進血管生成活性之含衍生自成體幹細胞之擬胞外體奈米囊胞之組成物及其製造方法
CN104955470A (zh) 利用了hmgb1片段的针对脊髄损伤的新型治疗方法
CN112891375B (zh) 一种神经干细胞外泌体经鼻吸收药物的制备方法及应用
Satani et al. Is immunomodulation a principal mechanism underlying how cell-based therapies enhance stroke recovery?
EP4173629A1 (en) Cranial nerve disorder therapeutic agent including culture supernatant of tissue cells derived from fetal appendage
JP2020504152A (ja) (+)−2−ボルネオールの、スフィンゴシンキナーゼ−1および/又はbdnfの発現の上方制御を促進する医薬の調製における使用
JP2022517531A5 (https=)
Zhao et al. Unleashing axonal regeneration capacities: neuronal and non-neuronal changes after injuries to dorsal root ganglion neuron central and peripheral axonal branches
Al-Shaibani et al. Cellular therapy for wounds: applications of mesenchymal stem cells in wound healing
CN112159793B (zh) 人脱落乳牙牙髓干细胞的应用
Chen et al. Immune characteristics of olfactory ensheathing cells and repair of nerve injury
Gasparyan et al. Influence of low level laser radiation on migration of stem cells
Li et al. A promising strategy for repairing tissue damage: mitochondria transfer from mesenchymal stem cells
WO2016041192A1 (zh) 藁本内酯的应用
Qu et al. Induction of substantial myocardial regeneration by an active fraction of the Chinese herb Rosa laevigata Michx
Gasparyan et al. Influence of low level laser radiation on migration of stem cells
KR102551880B1 (ko) 부신피질자극호르몬분비호르몬을 유효성분으로 포함하는 신경세포구 형성 촉진용 조성물
JP2016523975A (ja) 穿通性頭部外傷の処置におけるn−アセチルシステインアミドの使用
WO2016073801A1 (en) Low-level laser irradiation of stimulated human stem cells
Duan et al. Effect of electroacupuncture modulation of glycogen synthase kinase 3 beta/beta-catenin signaling pathway on CD133 protein expression in rat ventricular zone cells after spinal cord injury
He Research progress and prospects of mesenchymal stem cells for neurodegenerative disease treatment
CN105287657A (zh) 一种治疗癫痫病的银杏叶提取物及其用途
Gasparyan et al. Influence of laser radiation on migration of stem cells
CN117925501B (zh) 一种桔梗外泌体及其在制备治疗肺系疾病药物中的应用